[{"id":"a7efcdee-3084-4da3-8b4f-a986338621ca","acronym":"","url":"https://clinicaltrials.gov/study/NCT03019666","created_at":"2021-01-18T14:51:40.781Z","updated_at":"2024-07-02T16:36:01.005Z","phase":"Phase 1","brief_title":"Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL","source_id_and_acronym":"NCT03019666","lead_sponsor":"Masonic Cancer Center, University of Minnesota","biomarkers":" CD20","pipe":" | ","alterations":" CD20 positive • CD20 expression","tags":["CD20"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD20 positive • CD20 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • GDA-201"],"overall_status":"Completed","enrollment":" Enrollment 39","initiation":"Initiation: 10/18/2017","start_date":" 10/18/2017","primary_txt":" Primary completion: 08/15/2022","primary_completion_date":" 08/15/2022","study_txt":" Completion: 08/15/2022","study_completion_date":" 08/15/2022","last_update_posted":"2022-11-04"}]